Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs
In: ESMO Open, Jg. 6 (2021), Heft 6, S. 100320
academicJournal
Zugriff:
Titel: |
Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs
|
---|---|
Autor/in / Beteiligte Person: | Franken, M.G. ; Leeneman, B. ; Aarts, M.J.B. ; van Akkooi, A.C.J. ; van den Berkmortel, F.W.P.J. ; Boers-Sonderen, M.J. ; van den Eertwegh, A.J.M. ; de Groot, J.W.B. ; Hospers, G.A.P. ; Kapiteijn, E. ; Piersma, D. ; van Rijn, R.S. ; Suijkerbuijk, K.P.M. ; van der Veldt, A.A.M. ; Westgeest, H.M. ; Wouters, M.W.J.M. ; Haanen, J.B.A.G. ; Uyl-de Groot, C.A. |
Link: | |
Zeitschrift: | ESMO Open, Jg. 6 (2021), Heft 6, S. 100320 |
Veröffentlichung: | Elsevier BV, 2021 |
Medientyp: | academicJournal |
ISSN: | 2059-7029 |
DOI: | 10.1016/j.esmoop.2021.100320 |
Schlagwort: |
|
Sonstiges: |
|